Last reviewed · How we verify

NCT07093619

Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Gradient Centrifugation in a PGT-A Program: a Sibling Oocyte Study

Recruiting now NA Last updated 2 October 2025
What this trial tests

NA trial testing FERTILE Plus in Semen Analysis in 100 participants. Currently enrolling.

Timeline
12 September 2025
Primary endpoint
30 December 2026
30 December 2026

Quick facts

Lead sponsorART Fertility Clinics LLC
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment100
Start date12 September 2025
Primary completion30 December 2026
Estimated completion30 December 2026
Sites1 location across United Arab Emirates

Drugs / interventions tested

Conditions studied

Sponsor

ART Fertility Clinics LLC

Who can join

Eligibility, any sex, with Semen Analysis or ICSI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In assisted reproductive technology (ART), sperm preparation aims to select the most viable sperm for ICSI. Unlike conventional methods like density gradients or sperm washing, microfluidic techniques mimic natural selection in the female reproductive tract by using laminar flow without centrifugation, reducing the risk of DNA damage. This method isolates highly motile sperm while filtering out debris and immotile cells. Studies show that microfluidics improve embryo quality, increase pregnancy rates, and may lead to higher euploidy rates. Additional benefits include improved safety, scalability, and shorter preparation times.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Semen Analysis

Currently open trials in the same condition.

Other ART Fertility Clinics LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07093619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing